Proscia
Enterprise digital pathology software and AI applications for laboratories and life sciences.
What they do
The company develops the Concentriq platform, which digitizes pathology workflows and integrates artificial intelligence to help laboratories and research organizations manage and analyze massive image datasets. It helps pathologists diagnose cancer and other diseases with improved consistency.
The record
- Vertical
- Imaging & Diagnostics
- Sub-segment
- Digital pathology software
- Product type
- Platform software
- Stage
- Series C+
- Headquarters
- Philadelphia, USA
- Region
- North America
- Founded
- 2014
- Total funding
- $83M raised
Notable investors: Highland Capital Partners, Scale Venture Partners, Sorensen Capital, Hitachi Ventures.